Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
about
Exploring pathway interactions in insulin resistant mouse liverCB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptorsNonalcoholic fatty liver disease and aging: epidemiology to management.Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis.Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner.Apelin serum level in Egyptian patients with chronic hepatitis CDiabetes and Hepatitis C: A Two-Way Association.Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth.Protein tyrosine phosphatase 1B modulates GSK3β/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity.The Wide and Complex Field of NAFLD Biomarker Research: Trends.The Bcl-2 homology domain 3 (BH3)-only proteins Bim and bid are functionally active and restrained by anti-apoptotic Bcl-2 family proteins in healthy liver.Perturbations of lipid metabolism indexed by lipidomic biomarkers.Bifidobacterium breve with α-linolenic acid alters the composition, distribution and transcription factor activity associated with metabolism and absorption of fat.Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic Syndrome.Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling.Current understanding of insulin resistance in hepatitis C.Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis.The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative StudyCyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives.Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease.Natural products, an important resource for discovery of multitarget drugs and functional food for regulation of hepatic glucose metabolism.Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver.Apoptosis and non-alcoholic fatty liver diseases.
P2860
Q28530011-AF0DF218-7A51-4561-AD66-CB1C68AC1486Q28610813-4DE6F285-E403-4D29-8DCA-7CA200A02CDCQ34366861-7EAA652B-509E-4461-9E83-433CF26E0164Q34876724-33D1F827-3D6A-4C3E-AF1C-2488A0F4C9BEQ35068543-1467D5A8-93FC-4F69-AE3C-EC982F1FA007Q35294979-20122C84-E963-4B82-8399-91CD486A838EQ36056076-E52E63E4-DDA5-4A33-94E4-0F36F41393E1Q36465264-A9894316-4454-412E-8F75-163321CD14C0Q36521527-6F4B2056-C316-4247-B150-4F84808015FBQ36907101-C83077DB-9C6E-4687-BB96-AB5A3B4B3707Q36962085-A6D62849-27BD-4DC7-9B72-B3BA05259006Q37233959-F4813174-9654-4E54-8140-8D5EE68F62A5Q37512558-DDCB35D4-7503-49BD-B978-262A16E992C1Q37683805-F4D38035-84F9-4953-B359-CBDAA7F9CF45Q37690723-52912CAC-34EF-42EC-968C-56AA701F1312Q37726154-934958F2-BB0B-406A-9255-EAEF00BE3FE8Q37852704-2A72FEC7-C67E-4733-9ACE-04D9FCB88B23Q37903853-517946E5-7A1A-44EB-A0C7-621367088653Q38627620-0331B95A-B72C-4162-845F-8CDB7580EC57Q38660769-39D92BC9-7979-4477-8F2D-FC199EF6C1AEQ39036315-034219FA-58AA-4B8A-A289-E8B8F0274B66Q41528078-548D9AF7-5CFB-4A6F-9F22-864AB6FF4E74Q42239659-2D7057D6-7684-4BC8-95EA-31292C2EA489Q42345064-BDF9A524-7744-4076-B27A-D86B30A6AE27Q46957839-F157F14F-6C9D-40B9-A9A1-56E7168CF98BQ49325511-74925004-AF88-4F4A-A9EA-58B4B364F60EQ51016955-6172E617-EB06-4ADC-9110-92C3C2150B65Q55503094-A766F3F2-FC79-4869-9EC8-22F2FDF513F6
P2860
Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Hepatic insulin resistance is ...... titis and chronic hepatitis C.
@en
Hepatic insulin resistance is ...... titis and chronic hepatitis C.
@nl
type
label
Hepatic insulin resistance is ...... titis and chronic hepatitis C.
@en
Hepatic insulin resistance is ...... titis and chronic hepatitis C.
@nl
prefLabel
Hepatic insulin resistance is ...... titis and chronic hepatitis C.
@en
Hepatic insulin resistance is ...... titis and chronic hepatitis C.
@nl
P2093
P50
P1476
Hepatic insulin resistance is ...... atitis and chronic hepatitis C
@en
P2093
Angela M Valverde
Carmelo García-Monzón
Javier Vargas-Castrillón
Leonor García-Pozo
Marta Casado
María E Miquilena-Colina
Oreste Lo Iacono
Paloma Martín-Sanz
Tamara Lozano-Rodríguez
P304
P356
10.1016/J.JHEP.2010.06.021
P577
2010-08-27T00:00:00Z